168 related articles for article (PubMed ID: 12461588)
1. Cost of care for inpatients with community-acquired intra-abdominal infections.
Cattan P; Yin DD; Sarfati E; Lyu R; De Zelicourt M; Fagnani F
Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):787-93. PubMed ID: 12461588
[TBL] [Abstract][Full Text] [Related]
2. Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain.
Tellado JM; Sen SS; Caloto MT; Kumar RN; Nocea G
Scand J Infect Dis; 2007; 39(11-12):947-55. PubMed ID: 17852889
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
Marras TK; Nopmaneejumruslers C; Chan CK
Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic utilization and cost analysis in hospitalized patients with community-acquired pneumonia.
Stein GE; Mantz SL
Hosp Pharm; 1995 Feb; 30(2):132-4, 137. PubMed ID: 10140526
[TBL] [Abstract][Full Text] [Related]
5. Importance of appropriateness of empiric antibiotic therapy on clinical outcomes in intra-abdominal infections.
Baré M; Castells X; Garcia A; Riu M; Comas M; Egea MJ
Int J Technol Assess Health Care; 2006; 22(2):242-8. PubMed ID: 16571200
[TBL] [Abstract][Full Text] [Related]
6. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres.
Sheng WH; Wang JT; Lu DC; Chie WC; Chen YC; Chang SC
J Hosp Infect; 2005 Mar; 59(3):205-14. PubMed ID: 15694977
[TBL] [Abstract][Full Text] [Related]
7. Cost of Gram-negative resistance.
Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
[TBL] [Abstract][Full Text] [Related]
8. Blood cultures do not change management in hospitalized patients with community-acquired pneumonia.
Ramanujam P; Rathlev NK
Acad Emerg Med; 2006 Jul; 13(7):740-5. PubMed ID: 16766742
[TBL] [Abstract][Full Text] [Related]
9. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
[TBL] [Abstract][Full Text] [Related]
10. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
Houck PM; Bratzler DW; Nsa W; Ma A; Bartlett JG
Arch Intern Med; 2004 Mar; 164(6):637-44. PubMed ID: 15037492
[TBL] [Abstract][Full Text] [Related]
11. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
Frei CR; Restrepo MI; Mortensen EM; Burgess DS
Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
Bertrán MJ; Trilla A; Codina C; Carné X; Ribas J; Asenjo MA
Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
[TBL] [Abstract][Full Text] [Related]
13. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs.
Sturkenboom MC; Goettsch WG; Picelli G; in 't Veld B; Yin DD; de Jong RB; Go PM; Herings RM
Br J Clin Pharmacol; 2005 Oct; 60(4):438-43. PubMed ID: 16187977
[TBL] [Abstract][Full Text] [Related]
14. Impact of regular attendance by infectious disease specialists on the management of hospitalised adults with community-acquired febrile syndromes.
Borer A; Gilad J; Meydan N; Schlaeffer P; Riesenberg K; Schlaeffer F
Clin Microbiol Infect; 2004 Oct; 10(10):911-6. PubMed ID: 15373886
[TBL] [Abstract][Full Text] [Related]
15. Adherence to infectious diseases society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohort.
Wu JH; Howard DH; McGowan JE; Turpin RS; Henry Hu X
Clin Ther; 2006 Sep; 28(9):1451-61. PubMed ID: 17062317
[TBL] [Abstract][Full Text] [Related]
16. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
17. A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis.
Jackson J; Fernandes AW; Nelson W
Clin Ther; 2006 Sep; 28(9):1462-71. PubMed ID: 17062318
[TBL] [Abstract][Full Text] [Related]
18. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.
Hughes MG; Evans HL; Chong TW; Smith RL; Raymond DP; Pelletier SJ; Pruett TL; Sawyer RG
Crit Care Med; 2004 Jan; 32(1):53-60. PubMed ID: 14707559
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
[TBL] [Abstract][Full Text] [Related]
20. How long does it take to "rule out" bacteremia in children with central venous catheters?
Shah SS; Downes KJ; Elliott MR; Bell LM; McGowan KL; Metlay JP
Pediatrics; 2008 Jan; 121(1):135-41. PubMed ID: 18166567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
